Buy or sell Seven Bridges stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Seven Bridges Stock
Biomedical Data Science Company
About Seven Bridges Stock
Seven Bridges is the industry-leading infrastructure and data analytics company accelerating precision medicine by enabling the understanding of biomedical data. Our platform, services, and support expertise are driving discovery and drug development at the world’s leading academic, biotechnology, government, hospitals, and pharmaceutical entities. Through our collaborations with the largest genomics projects, we connect the world’s biomedical information to enable the most efficient analysis at scale. Named one of the world's smartest companies by MIT Technology Review, and a three-time Bio-IT World Best of Show winner, Seven Bridges has offices in Belgrade, Boston, Istanbul, and San Francisco.
Investors
First Star Ventures
Kryssen Capital
Funding History
| September 2014 | $3.0M |
|---|---|
| February 2016 | $45.0M |
| April 2018 | $50.0M |
| April 2021 | $15.0M |
Management
Chief Executive Officer
William Moss
Chief Financial Officer
Robert Shay
Chief Technology Officer
David Ramos
Press
genomeweb - Sep, 9 2021
bit - Aug, 26 2021
aithority - Mar, 4 2021
pharmiweb - Sep, 23 2020
zpr - Dec, 18 2019
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Seven Bridges or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
